RETRACTED: KDM4A promotes the growth of non-small cell lung cancer by mediating the expression of Myc via DLX5 through the Wnt/β-catenin signaling pathway
Authors:
- 1 December 2020
- journal article
- retracted article
- Published by Elsevier in Life Sciences
- Vol. 262, 118508
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Jumonji domain containing 2A predicts prognosis and regulates cell growth in lung cancer depending on miR-150Oncology Reports, 2015
- Histone Demethylases KDM4A and KDM4C Regulate Differentiation of Embryonic Stem Cells to Endothelial CellsStem Cell Reports, 2015
- Immunotherapy for Lung Cancer: Has it Finally Arrived?Frontiers in Oncology, 2014
- Exome sequencing reveals a heterozygous DLX5 mutation in a Chinese family with autosomal-dominant split-hand/foot malformationEuropean Journal of Human Genetics, 2014
- Epidemiology of Lung CancerChest, 2013
- JMJD2A Promotes Cellular Transformation by Blocking Cellular Senescence through Transcriptional Repression of the Tumor Suppressor CHD5Cell Reports, 2012
- Oncogenic features of the JMJD2A histone demethylase in breast cancerInternational Journal of Oncology, 2012
- The JMJD2A demethylase regulates apoptosis and proliferation in colon cancer cellsJournal of Cellular Biochemistry, 2011
- Mutually exclusive expression of DLX2 and DLX5/6 is associated with the metastatic potential of the human breast cancer cell line MDA-MB-231BMC Cancer, 2010
- DLX5 (Distal-less Homeobox 5) Promotes Tumor Cell Proliferation by Transcriptionally Regulating MYCJournal of Biological Chemistry, 2009